237 related articles for article (PubMed ID: 24909143)
1. Long-term impact of neonatal inflammation on demyelination and remyelination in the central nervous system.
Bénardais K; Gudi V; Gai L; Neßler J; Singh V; Prajeeth CK; Skripuletz T; Stangel M
Glia; 2014 Oct; 62(10):1659-70. PubMed ID: 24909143
[TBL] [Abstract][Full Text] [Related]
2. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Tanaka T; Murakami K; Bando Y; Yoshida S
J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system.
Skripuletz T; Miller E; Grote L; Gudi V; Pul R; Voss E; Skuljec J; Moharregh-Khiabani D; Trebst C; Stangel M
Brain Behav Immun; 2011 Nov; 25(8):1592-606. PubMed ID: 21635946
[TBL] [Abstract][Full Text] [Related]
4. Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination.
Plant SR; Arnett HA; Ting JP
Glia; 2005 Jan; 49(1):1-14. PubMed ID: 15382206
[TBL] [Abstract][Full Text] [Related]
5. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Steelman AJ; Thompson JP; Li J
Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
[TBL] [Abstract][Full Text] [Related]
6. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
Taylor LC; Gilmore W; Ting JP; Matsushima GK
J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424
[TBL] [Abstract][Full Text] [Related]
7. Gene expression in brain during cuprizone-induced demyelination and remyelination.
Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
9. Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.
Tejedor LS; Wostradowski T; Gingele S; Skripuletz T; Gudi V; Stangel M
J Mol Neurosci; 2017 Apr; 61(4):479-488. PubMed ID: 28124770
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination.
Urbach-Ross D; Kusnecov AW
Brain Behav Immun; 2007 Oct; 21(7):962-74. PubMed ID: 17490854
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Salinas Tejedor L; Berner G; Jacobsen K; Gudi V; Jungwirth N; Hansmann F; Gingele S; Prajeeth CK; Baumgärtner W; Hoffmann A; Skripuletz T; Stangel M
Brain Behav Immun; 2015 Nov; 50():155-165. PubMed ID: 26140734
[TBL] [Abstract][Full Text] [Related]
13. TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model.
Iocca HA; Plant SR; Wang Y; Runkel L; O'Connor BP; Lundsmith ET; Hahm K; van Deventer HW; Burkly LC; Ting JP
J Neuroimmunol; 2008 Feb; 194(1-2):97-106. PubMed ID: 18207576
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
Skripuletz T; Hackstette D; Bauer K; Gudi V; Pul R; Voss E; Berger K; Kipp M; Baumgärtner W; Stangel M
Brain; 2013 Jan; 136(Pt 1):147-67. PubMed ID: 23266461
[TBL] [Abstract][Full Text] [Related]
15. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
16. Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.
Martin NA; Molnar V; Szilagyi GT; Elkjaer ML; Nawrocki A; Okarmus J; Wlodarczyk A; Thygesen EK; Palkovits M; Gallyas F; Larsen MR; Lassmann H; Benedikz E; Owens T; Svenningsen AF; Illes Z
Front Immunol; 2018; 9():490. PubMed ID: 29593734
[TBL] [Abstract][Full Text] [Related]
17. Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.
Paez PM; Cheli VT; Ghiani CA; Spreuer V; Handley VW; Campagnoni AT
Glia; 2012 Jul; 60(7):1078-93. PubMed ID: 22447683
[TBL] [Abstract][Full Text] [Related]
18. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.
Matsushima GK; Morell P
Brain Pathol; 2001 Jan; 11(1):107-16. PubMed ID: 11145196
[TBL] [Abstract][Full Text] [Related]
19. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
20. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.
Liu L; Belkadi A; Darnall L; Hu T; Drescher C; Cotleur AC; Padovani-Claudio D; He T; Choi K; Lane TE; Miller RH; Ransohoff RM
Nat Neurosci; 2010 Mar; 13(3):319-26. PubMed ID: 20154684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
